Compare · CRM vs SNCE
CRM vs SNCE
Side-by-side comparison of Salesforce Inc. (CRM) and Science 37 Holdings Inc. (SNCE): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CRM and SNCE operate in Computer Software: Prepackaged Software (Technology), so they compete in similar markets.
- CRM carries a market cap of $156.70B.
- CRM has hit the wire 4 times in the past 4 weeks while SNCE has been quiet.
- CRM has more recent analyst coverage (25 ratings vs 5 for SNCE).
- Company
- Salesforce Inc.
- Science 37 Holdings Inc.
- Price
- $190.38-2.17%
- -
- Market cap
- $156.70B
- -
- 1M return
- -19.70%
- -
- 1Y return
- -16.65%
- -
- Industry
- Computer Software: Prepackaged Software
- Computer Software: Prepackaged Software
- Exchange
- NYSE
- NASDAQ
- IPO
- 2004
- 2020
- News (4w)
- 4
- 0
- Recent ratings
- 25
- 5
Salesforce Inc.
salesforce.com, inc. develops enterprise cloud computing solutions with a focus on customer relationship management worldwide. The company offers Sales Cloud to store data, monitor leads and progress, forecast opportunities, and gain insights through analytics and relationship intelligence, as well as deliver quotes, contracts, and invoices. It also provides Service Cloud, which enables companies to deliver personalized customer service and support, as well as a field service solution that enables companies to connect agents, dispatchers, and mobile employees through a centralized platform, which helps to schedule and dispatch work, and track and manage jobs in real-time. In addition, the company offers Marketing Cloud to plan, personalize, and optimize one-to-one customer marketing interactions; and Commerce Cloud, which enables companies to enhance engagement, conversion, revenue, and loyalty from their customers. Further, it provides Customer 360 Platform that offers no-code to pro-code Platform-as-a-Service tools for building, securing, integrating, and managing the business apps; MuleSoft Anypoint Platform enables customers to connect any system, application, data, or device; Quip collaboration platform, which combines documents, spreadsheets, apps, and chat with live CRM data; and Tableau and Einstein Analytics, provides analytical technology to customers. Additionally, the company offers various solutions for financial services, healthcare and life sciences, manufacturing, consumer goods, government, and philanthropy. The company also provides professional services and education services, including instructor-led and online courses; and support and adoption programs. It provides its services through direct sales; and consulting firms, systems integrators, and other partners. Salesforce and Siemens has a strategic partnership. The company was founded in 1999 and is headquartered in San Francisco, California.
Latest CRM
- Salesforce Announces Date of Third Quarter Fiscal 2027 Earnings Release and Webcast
- Missionforce National Security Achieves ‘Awardable’ Status for Department of War Recruiting Capabilities in the CDAO's Tradewinds Solutions Marketplace
- SEC Form S-8 filed by Salesforce Inc.
- SEC Form S-8 filed by Salesforce Inc.
- SEC Form 4 filed by Salesforce Inc.
- Salesforce Grants Equity Awards to m3ter and Fin Under Its Inducement Equity Incentive Plan
- SEC Form 8-K filed by Salesforce Inc.
- Salesforce Signs Definitive Agreement to Acquire Braze
- Docusign and Salesforce Launch Intelligent Agreement Management Natively Across Salesforce to Power Agentic Agreement Workflows
- Salesforce upgraded by BofA Securities with a new price target
Latest SNCE
- Science 37 Completes Third FDA Inspection, Validating Quality of its Direct-to-Patient Site in Pivotal Phase 3 Rare Disease Trial
- Science 37 and Catalent Announce Partnership Enabling Universal Access to Clinical Research
- Science 37 Completes Second FDA Inspection as Enrollment Leader in Phase 3 Asthma Trial
- Science 37 Appoints Tyler Van Horn as CEO to Lead Next Era of Patient-Access Innovation
- Science 37 Nearly Doubles U.S. Enrollment for GSK Phase 3 Rare Disease Trial
- Science 37 Unveils New Corporate Headquarters in Research Triangle Park, NC
- Science 37 Enrolls 42% of Trial Cohort in 8 Weeks
- Science 37 Quickly Impacts Performance in Under-Enrolling Clinical Trials
- Science 37 Surpasses Enrollment Goals, Accelerates Phase 2 Rare Disease Clinical Trial
- Science 37 Metasite™ Undergoes Successful FDA Inspection, Marking Major Milestone in Virtual Site Quality Assurance and Compliance